Vaxcyte prices USD 575 million 1.50% convertible senior notes due 2032 offering

Bitget2026/10/09 20:43

Vaxcyte closed a USD 575 million offering of 1.50% Convertible Senior Notes due 2032 under an indenture with U.S. Bank Trust. Interest payable semiannually starting April 15, 2027; maturity Oct. 15, 2032 unless earlier converted, redeemed, or repurchased. Initial conversion rate 11 shares per USD 1,000 principal; initial conversion price about USD 89.60 per share. Issuer redemption allowed from Oct. 22, 2029 if the stock trades above 130% of the conversion price under specified conditions. Investors can require cash repurchase upon a Fundamental Change; bankruptcy-related default triggers immediate acceleration. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-419174), on October 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The value of cryptocurrency assets held by the U.S. government has shrunk by $16 billion from last year’s peak.

AiCoin•2026/10/11 03:23

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35